arginine has been researched along with iloprost in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (55.56) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Braun, MS; Heckenberger, RE; Klockenbusch, W; Schröder, H; Schrör, K; Strobach, H | 1 |
Schröder, H; Schrör, K; Strobach, H | 1 |
Mollace, V; Salvemini, D; Vane, J | 1 |
Dembinska-Kiec, A; Pallapies, D; Peskar, BA; Peskar, BM; Simmet, T | 1 |
Anfossi, G; Cavalot, F; Massucco, P; Mattiello, L; Mularoni, E; Trovati, M | 1 |
Enami, T; Hoson, M; Kashimura, T; Kawada, T; Mochizuki, A; Nakada, K; Wakisaka, M; Yamate, N | 1 |
Gryglewski, RJ; Swies, J | 1 |
Cohen, H; Enayat, ZE; Flores, NA; Goulielmos, NV; Sheridan, DJ | 1 |
Apaydin, I; Emiroğlu, M; Erçöçen, AR; Ergün, H; Gültan, SM; Yormuk, E | 1 |
Donello, JE; Gil, DW; Kedzie, KM; Krauss, HA; Regan, JW | 1 |
Howard, LS; Morrell, NW | 1 |
Auteri, A; Blardi, P; Ceccatelli, L; De Franco, V; de Lalla, A; Meini, S; Pieragalli, D | 1 |
Rolfes, C; Steinfeldt, T | 1 |
Bara, C; Gras, C; Hafer, C; Haverich, A; Kuehn, C; Malehsa, D; Meyer, AL; Strüber, M | 1 |
Atli, O; Demirel-Yilmaz, E; Ilgin, S; Sirmagul, B; Usanmaz, SE | 1 |
Senol, A; Senol, S | 1 |
Bünemann, M; Krett, AL; Kurz, M | 1 |
1 review(s) available for arginine and iloprost
Article | Year |
---|---|
New therapeutic agents for pulmonary vascular disease.
Topics: Adult; Antihypertensive Agents; Arginine; Bosentan; Child; Drug Therapy, Combination; Epoprostenol; Humans; Hypertension, Pulmonary; Iloprost; Nitric Oxide; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Sulfonamides | 2005 |
1 trial(s) available for arginine and iloprost
Article | Year |
---|---|
Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Blood Platelets; Blood Pressure; Diabetes Mellitus, Type 2; Drug Administration Schedule; Exercise Test; Female; Humans; Iloprost; Infusions, Intravenous; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Serotonin; Treatment Outcome | 2006 |
16 other study(ies) available for arginine and iloprost
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prostacyclin rather than nitric oxide lowers human umbilical artery tone in vitro.
Topics: Arginine; Bradykinin; Cyclic GMP; Epoprostenol; Female; Histamine; Humans; Iloprost; In Vitro Techniques; Indomethacin; Molsidomine; Muscle Contraction; Nitric Oxide; Nitroarginine; Serotonin; Umbilical Arteries; Vasodilation | 1992 |
Nitric oxide but not prostacyclin is an autocrine endothelial mediator.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Calcimycin; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic GMP; Dinoprostone; Endothelium, Vascular; Epoprostenol; Iloprost; Nitric Oxide; omega-N-Methylarginine; Second Messenger Systems; Swine | 1992 |
Studies on the importance of the proposed release of nitric oxide from platelets.
Topics: Arginine; Blood Platelets; Collagen; Humans; Iloprost; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin | 1991 |
Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.
Topics: Animals; Aorta; Arginine; Carbenoxolone; Gastric Mucosa; Humans; Iloprost; In Vitro Techniques; Male; Methylene Blue; Molsidomine; Muscle Relaxation; Muscle Tonus; Neutrophils; Nitric Oxide; Nitroarginine; Nitroprusside; Oxyhemoglobins; Rats; Rats, Inbred Strains; Stomach Ulcer; Vasodilator Agents | 1991 |
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate; Adult; Arginine; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Epinephrine; Humans; Iloprost; Intracellular Fluid; Male; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 4; Second Messenger Systems | 1993 |
Characterization of platelet activity in neuroblastoma.
Topics: Antithrombins; Arginine; Child, Preschool; Female; Humans; Iloprost; Infant; Infant, Newborn; Kidney Neoplasms; Male; Neuroblastoma; Pheochromocytoma; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Tissue Extracts; Wilms Tumor | 1994 |
Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
Topics: Animals; Arginine; Aspirin; Blood Pressure; Cats; Epoprostenol; Extracorporeal Circulation; Fibrinolysis; Heparitin Sulfate; Iloprost; Infusions, Intravenous; Injections, Intravenous; Molsidomine; Nitric Oxide; Nitroarginine; Platelet Aggregation; Streptokinase; Thrombosis; Vasodilator Agents | 1995 |
Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
Topics: Action Potentials; Adenosine Diphosphate; Animals; Arginine; Blood Platelets; Collagen; Epoprostenol; Guinea Pigs; Heart; Hemoglobins; Iloprost; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Platelet Aggregation Inhibitors; Vasodilator Agents | 1995 |
The effects of L-arginine and iloprost on the viability of random skin flaps in rats.
Topics: Animals; Arginine; Drug Therapy, Combination; Graft Survival; Iloprost; Male; Microcirculation; Necrosis; Nitric Oxide; Rats; Rats, Wistar; Surgical Flaps; Vasodilator Agents | 1998 |
A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs.
Topics: Alprostadil; Amino Acid Sequence; Arginine; Dinoprostone; Humans; Iloprost; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Phylogeny; Prostaglandins; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Sequence Homology, Amino Acid | 1998 |
[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Topics: Acute Kidney Injury; Anticoagulants; Arginine; Blood Coagulation Tests; Chondroitin Sulfates; Citrates; Critical Care; Dermatan Sulfate; Diagnostic Errors; Dose-Response Relationship, Drug; Epoprostenol; Fondaparinux; Hemofiltration; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Iloprost; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sodium Citrate; Sulfonamides; Thrombocytopenia; Thrombosis | 2008 |
HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart-Assist Devices; Heparin; Humans; Iloprost; Length of Stay; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Implantation; Sulfonamides; Thrombocytopenia; Warfarin | 2009 |
Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.
Topics: Animals; Aorta, Thoracic; Arginine; Disease Models, Animal; Endothelium, Vascular; Hydrogen Sulfide; Hypertension, Pulmonary; Iloprost; Male; Monocrotaline; Nitric Oxide; Piperazines; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2013 |
Investigation of Asymmetric and Symmetric Dimethylarginine Levels after Iloprost Treatment in Patients with Buerger's Disease.
Topics: Adult; Aged; Arginine; Biomarkers; Female; Humans; Iloprost; Infusions, Intravenous; Male; Middle Aged; Thromboangiitis Obliterans; Time Factors; Treatment Outcome; Vasodilator Agents | 2017 |
Voltage Dependence of Prostanoid Receptors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arginine; Binding Sites; Cell Membrane; Fluorescence Resonance Energy Transfer; HEK293 Cells; Humans; Iloprost; Ligands; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Receptors, Epoprostenol; Receptors, Prostaglandin; Recombinant Proteins; Signal Transduction; Transfection | 2020 |